| [1] |
|
| [2] |
|
| [3] |
Lin YH, Chen YH, Chang HY，et al. Chronic niche inflammation in endometriosis-associated infertility: current understanding and future therapeutic strategies[J]. Int J Mol Sci, 2018，19(8): 2385. DOI: 10.3390/ijms19082385. |
| [4] |
Cheng Y, Li L, Wang D，et al. Characteristics of human endometrium-derived mesenchymal stem cells and their tropism to endometriosis[J]. Stem Cells Int，2017, 2017：4794827.DOI: 10.1155/2017/4794827. |
| [5] |
Cousins FL, O DF, Gargett CE. Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis[J]. Best Pract Res Clin Obstet Gynaecol, 2018, 50: 27-38.DOI： 10.1016/j.bpobgyn.2018.01.011. |
| [6] |
Koippallil Gopalakrishnan AR, Kishore U, Madan T. Mesenchymal stem cells: a promising tool for targeted gene therapy of endometriosis[J]. Regen Med, 2017, 12(1)：69-76.DOI： 10.2217/rme-2016-0084. |
| [7] |
El Sabeh M, Afrin S, Singh B, et al. Uterine stem cells and benign gynecological disorders: role in pathobiology and therapeutic implications[J]. Stem Cell Rev Rep, 2020. DOI: 10.1007/s12015-020-10075-w. |
| [8] |
Laganà AS, Garzon S, Götte M, et al. The pathogenesis of endometriosis：molecular and cell biology insights[J]. Int J Mol Sci, 2019, 20(22): 5615. DOI: 10.3390/ijms20225615. |
| [9] |
|
| [10] |
Berebichez-Fridman R, Montero-Olvera PR. Sources and clinical applications of mesenchymal stem cells: state-of-the-art review[J]. Sultan Qaboos Univ Med J，2018, 18(3)：e264-e277.DOI: 10.18295/squmj.2018.18.03.002. |
| [11] |
Simoni M, Taylor HS. Therapeutic strategies involving uterine stem cells in reproductive medicine[J]. Curr Opin Obstet Gynecol, 2018, 30(3)：209-216.DOI: 10.1097/GCO.0000000000000457. |
| [12] |
Gargett CE, Schwab KE, Deane JA. Endometrial stem/progenitor cells: the first 10 years[J]. Hum Reprod Update, 2016, 22(2)：137-163.DOI: 10.1093/humupd/dmv051. |
| [13] |
Sasson IE, Taylor HS. Stem cells and the pathogenesis of endometriosis[J]. Ann N Y Acad Sci, 2008, 1127：106-115.DOI： 10.1196/annals.1434.014. |
| [14] |
Tempest N, Maclean A, Hapangama DK. Endometrial stem cell markers: current concepts and unresolved questions[J]. Int J Mol Sci, 2018, 19(10): 3240. DOI: 10.3390/ijms19103240. |
| [15] |
Pluchino N, Taylor HS. Endometriosis and stem cell trafficking[J]. Reprod Sci，2016, 23(12)：1616-1619.DOI: 10.1177/1933719116671219. |
| [16] |
Santamaria X, Mas A, Cervelló I, et al. Uterine stem cells: from basic research to advanced cell therapies[J]. Hum Reprod Update, 2018, 24(6)：673-693.DOI: 10.1093/humupd/dmy028. |
| [17] |
Ong YR, Cousins FL, Yang X, et al. Bone marrow stem cells do not contribute to endometrial cell lineages in chimeric mouse models[J]. Stem Cells, 2018, 36(1): 91-102. DOI: 10.1002/stem.2706. |
| [18] |
Li F, Alderman MH3rd, Tal A, et al. Hematogenous dissemination of mesenchymal stem cells from endometriosis[J]. Stem Cells, 2018, 36(6)：881-890.DOI: 10.1002/stem.2804. |
| [19] |
Moridi I, Mamillapalli R, Cosar E. Bone marrow stem cell chemotactic activity is induced by elevated CXCL12 in endometriosis[J]. Reprod Sci, 2017, 24(4)：526-533.DOI: 10.1177/1933719116672587. |
| [20] |
Zhang W, Li X, Li H, et al. 17β-estradiol promotes bone marrow mesenchymal stem cell migration mediated by chemokine upregulation[J]. Biochem Biophys Res Commun, 2020, 530(2): 381-388. DOI: 10.1016/j.bbrc.2020.07.135. |
| [21] |
Chen P, Mamillapalli R, Habata S, et al. Endometriosis cell proliferation induced by bone marrow mesenchymal stem cells[J]. Reprod Sci, 2021, 8(2): 426-434. DOI: 10.1007/s43032-020-00294-4. |
| [22] |
Nguyen HPT, Xiao L, Deane JA, et al. N-cadherin identifies human endometrial epithelial progenitor cells by in vitro stem cell assays[J]. Hum Reprod，2017, 32(11)：2254-2268.DOI: 10.1093/humrep/dex289. |
| [23] |
Esfandyari S, Chugh RM, Park HS, et al. Mesenchymal stem cells as a bio organ for treatment of female infertility[J]. Cells, 2020, 9(10): 2253. DOI: 10.3390/cells9102253. |
| [24] |
Zhou X, Xu B, Zhang D, et al. Loss of CDYL results in suppression of CTNNB1 and decreased endometrial receptivity[J]. Front Cell Dev Biol，2020, 8：105.DOI: 10.3389/fcell.2020.00105. |
| [25] |
Liu Y, Liang S, Yang F, et al. Biological characteristics of endometriotic mesenchymal stem cells isolated from ectopic lesions of patients with endometriosis[J]. Stem Cell Res Ther, 2020, 11(1): 346. DOI: 10.1186/s13287-020-01856-8. |
| [26] |
Susheelamma CJ, Pillai SM, Asha Nair S. Oestrogen, progesterone and stem cells: the discordant trio in endometriosis？[J]. Expert Rev Mol Med，2018, 20：e2.DOI: 10.1017/erm.2017.13. |
| [27] |
Abdel-Rasheed M, Nour Eldeen G, Mahmoud M, et al. MicroRNA expression analysis in endometriotic serum treated mesenchymal stem cells[J]. EXCLI J, 2017, 16: 852-867. DOI: 10.17179/excli2017-101. |
| [28] |
Anglesio MS, Papadopoulos N, Ayhan A, et al. Cancer-associated mutations in endometriosis without cancer[J]. N Engl J Med, 2017, 376(19): 1835-1848. DOI: 10.1056/NEJMoa1614814. |
| [29] |
Savilova AM, Farkhat KN, Yushina MN, et al. Characteristics of multipotent mesenchymal stromal cells isolated from the endometrium and endometriosis lesions of women with malformations of the internal reproductive organs[J]. Bull Exp Biol Med, 2017, 162(4): 539-544.DOI: 10.1007/s10517-017-3656-7. |
| [30] |
Abomaray F, Gidlöf S, Götherström C. Mesenchymal stromal cells are more immunosuppressive in vitro if they are derived from endometriotic lesions than from eutopic endometrium[J]. Stem Cells Int, 2017, 2017：3215962.DOI: 10.1155/2017/3215962. |
| [31] |
Li J, Dai Y, Zhu H, et al. Endometriotic mesenchymal stem cells significantly promote fibrogenesis in ovarian endometrioma through the Wnt/β-catenin pathway by paracrine production of TGF-β1 and Wnt1[J]. Hum Reprod, 2016, 31(6): 1224-1235. DOI: 10.1093/humrep/dew058. |
| [32] |
|
| [33] |
Liu Y, Zhang Z, Yang F, et al. The role of endometrial stem cells in the pathogenesis of endometriosis and their application to its early diagnosis[J]. Biol Reprod, 2020, 102(6): 1153-1159. DOI: 10.1093/biolre/ioaa011. |
| [34] |
Koippallil Gopalakrishnan AR, Pandit H, Metkari SM, et al. Adenoviral vector encoding soluble Flt-1 engineered human endometrial mesenchymal stem cells effectively regress endometriotic lesions in NOD/SCID mice[J]. Gene Ther, 2016, 23(7): 580-591. DOI: 10.1038/gt.2016.30. |
| [35] |
Ersoy GS, Zolbin MM, Cosar E, et al. Medical therapies for endometriosis differentially inhibit stem cell recruitment[J]. Reprod Sci, 2017, 24(6)：818-823.DOI: 10.1177/1933719116682879. |
| [36] |
Ramirez Williams L, Brüggemann K, Hubert M, et al. γ-Secretase inhibition affects viability, apoptosis, and the stem cell phenotype of endometriotic cells[J]. Acta Obstet Gynecol Scand, 2019, 98(12): 1565-1574. DOI: 10.1111/aogs.13707. |
| [37] |
Taghizadeh M, Noruzinia M. Lovastatin reduces stemness via epigenetic reprograming of BMP2 and GATA2 in human endometrium and endometriosis[J]. Cell J, 2017, 19(1): 50-64. DOI: 10.22074/cellj.2016.3894. |
| [38] |
Pluchino N, Mamillapalli R, Shaikh S, et al. CXCR4 or CXCR7 antagonists treat endometriosis by reducing bone marrow cell trafficking[J]. J Cell Mol Med, 2020, 24(4): 2464-2474. DOI: 10.1111/jcmm.14933. |